ABOUT
Overview
Executive Management
Board of Directors
PRODUCTS
Pliaglis
PIPELINE
INVESTORS
Overview
Annual General Meeting
Corporate Governance
Shareholder Information
Stock Quote
Press Releases
Financial Reporting
Presentations
Request Information
TECHNOLOGY
Overview
MMPE
DuraPeel
CONTACT
Navigate to...
ABOUT
– Overview
– Executive Management
– Board of Directors
PRODUCTS
– Pliaglis
PIPELINE
INVESTORS
– Overview
– Corporate Governance
– Shareholder Information
– Stock Quote
– Press Releases
– Financial Reporting
– Presentations
– Request Information
TECHNOLOGY
– Overview
– MMPE
– DuraPeel
CONTACT
Press Releases
Home
»
Investors
»
Press Releases
Recent News
Year
All Years
2021
2020
2019
2018
2017
2016
Keywords
Go
Advanced Search
Search
Search Headlines Only
From
To
Apr 17, 2019
Crescita Therapeutics to Present at the 2019 Bloom Burton & Co. Healthcare Investor Conference in Toronto
Mar 21, 2019
Crescita Therapeutics Reports Fourth Quarter and Fiscal 2018 Results Record Annual Revenue of $16.6M and Adjusted EBITDA of $1.5M Strong Royalties and Sales Milestones
Feb 4, 2019
Crescita Therapeutics Inc.™ and Tetra Natural Health Collaborate to Enhance Transdermal Delivery of Beta-Caryophyllene in Tetra's Dermatology Product Portfolio
Dec 17, 2018
U.S. FDA Approves Removal of "Not for Home Use" Label Restriction for Pliaglis®
Nov 9, 2018
Crescita Therapeutics™ Reports 2018 Third Quarter Results Strong Royalty Revenue and Achievement of First Pliaglis US Sales Milestone Positive Adjusted EBITDA of $0.8M
Show
5
10
25
50
100
per page
«
1
…
4
5
6
7
8
9
10
…
15
»
Back To Top
